• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物化合物的体外药物溶出研究。

In-Vitro Drug Dissolution Studies in Medicinal Compounds.

机构信息

Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey.

Department of Pharmaceutical Sciences, Gulhane Health Science Institute, Health Science University, Ankara, Turkey.

出版信息

Curr Med Chem. 2018;25(33):4020-4036. doi: 10.2174/0929867325666180322145335.

DOI:10.2174/0929867325666180322145335
PMID:29577852
Abstract

After oral administration, drug absorption from solid dosage forms depends on the release of the drug active compounds from the dosage form, the dissolution or solubilization of the drug under physiological conditions, and the permeability across the gastrointestinal tract. Dissolution testing is an essential part of designing more effective solid dosage forms in pharmaceutical industry. Moreover, dissolution testing contributes to the selection of appropriate formulation excipients for improving the dosage form efficiency. This study aims to analyze in-vitro drug dissolution testing in solid dosage forms since 2010 in order to present a comprehensive outlook of recent trends. In doing that the previous studies in the literature are summarized in the form of a table to demonstrate the apparatuses used for dissolution testing, the media in which the solid dosage form is dissolved, the method preferred for analysis from dissolution media, the conditions of analyses and the results obtained.

摘要

口服固体制剂的药物吸收取决于药物活性化合物从剂型中的释放、生理条件下药物的溶解或溶出以及穿过胃肠道的通透性。溶出度测试是制药行业设计更有效固体制剂的重要组成部分。此外,溶出度测试有助于选择适当的制剂辅料,以提高剂型效率。本研究旨在分析 2010 年以来固体制剂的体外药物溶出度测试,以呈现近期趋势的全面概况。为此,以表格形式总结了文献中的先前研究,以展示用于溶出度测试的仪器、溶解固体制剂的介质、从溶出介质中首选的分析方法、分析条件和获得的结果。

相似文献

1
In-Vitro Drug Dissolution Studies in Medicinal Compounds.药物化合物的体外药物溶出研究。
Curr Med Chem. 2018;25(33):4020-4036. doi: 10.2174/0929867325666180322145335.
2
FIP Guidelines for Dissolution Testing of Solid Oral Products.FIP 指导原则:固体制剂溶出度测试
J Pharm Sci. 2018 Dec;107(12):2995-3002. doi: 10.1016/j.xphs.2018.08.007. Epub 2018 Aug 25.
3
Microenvironmental pH modulation in solid dosage forms.固体剂型中的微环境pH调节
J Pharm Sci. 2007 May;96(5):948-59. doi: 10.1002/jps.20932.
4
Current perspectives in dissolution testing of conventional and novel dosage forms.传统剂型与新型剂型溶出度测试的当前观点
Int J Pharm. 2007 Jan 2;328(1):12-21. doi: 10.1016/j.ijpharm.2006.10.001. Epub 2006 Oct 6.
5
Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.利用流体分配和强制干燥技术从药物纳米混悬剂制备固体制剂的替代制造概念。
J Pharm Sci. 2018 Mar;107(3):909-921. doi: 10.1016/j.xphs.2017.11.007. Epub 2017 Nov 16.
6
Computer simulations using GastroPlus to justify a biowaiver for etoricoxib solid oral drug products.使用 GastroPlus 进行计算机模拟以证明依托考昔固体口服药品的生物等效豁免。
Eur J Pharm Biopharm. 2009 May;72(1):91-8. doi: 10.1016/j.ejpb.2008.10.019. Epub 2008 Nov 21.
7
Drug dissolution: significance of physicochemical properties and physiological conditions.药物溶解:物理化学性质和生理条件的重要性
Drug Discov Today. 2013 Dec;18(23-24):1173-84. doi: 10.1016/j.drudis.2013.08.013. Epub 2013 Sep 13.
8
Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System.基于生理学的体外模型预测固体药物递送系统的口服溶解与吸收
Curr Drug Metab. 2015;16(9):777-806. doi: 10.2174/1389200216666150812123836.
9
Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.速释固体口服剂型的生物豁免说明书:酮洛芬。
J Pharm Sci. 2012 Oct;101(10):3593-603. doi: 10.1002/jps.23233. Epub 2012 Jul 11.
10
Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.采用体外-体内模拟方法分析禁食状态下人用非诺贝特脂制剂的口服生物利用度增强。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1274-84. doi: 10.1016/j.ejpb.2013.03.001. Epub 2013 Mar 14.

引用本文的文献

1
Superior Dissolution Behavior and Bioavailability of Pharmaceutical Cocrystals and Recent Regulatory Issues.药用共晶体的卓越溶出行为与生物利用度及近期监管问题
ACS Med Chem Lett. 2021 Dec 30;13(1):29-37. doi: 10.1021/acsmedchemlett.1c00478. eCollection 2022 Jan 13.